Late-breaking abstract: Pre-clinical efficacy of RP5090 in PI3Kδ mediated airway disorders

K. Routhu, K. Varanasi, S. Veeraraghavan, M. Muthuppalaniappan, G. Babu, S. Viswanadha, S. Vakkalanka (Hyderabad, India)

Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease
Session: Late-Breaking Abstracts Session: New treatments and targets for airway disease
Session type: Oral Presentation
Number: 4495
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Routhu, K. Varanasi, S. Veeraraghavan, M. Muthuppalaniappan, G. Babu, S. Viswanadha, S. Vakkalanka (Hyderabad, India). Late-breaking abstract: Pre-clinical efficacy of RP5090 in PI3Kδ mediated airway disorders. Eur Respir J 2011; 38: Suppl. 55, 4495

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late-breaking abstract: Further studies on the mechanism of action of doxofylline
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease
Year: 2011


Late-breaking abstract: Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthma
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease
Year: 2011

Late-breaking abstract: Genome-wide association of GLCCI1 with asthma steroid treatment response
Source: Annual Congress 2011 - Phenotyping asthma: a clue for treatments?
Year: 2011

Late-breaking abstract: Pre-clinical characterization of RP3128, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease
Year: 2011


Safety of formoterol in asthma clinical trials: an update
Source: Eur Respir J 2014; 43: 103-114
Year: 2004



Paradoxical response to bronchodilators: Radiologic correlates and clinical implications
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014


Late-breaking abstract: HR-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease
Source: Annual Congress 2011 - COPD: integrated care and rehabilitation
Year: 2011

Initial trials of precision medicine approaches in airway disease
Source: ERS Research Seminar 2017 – Precision medicine in airway diseases
Year: 2017


Pulmonary fibrosis: ongoing trials and future treatment
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010

Bronchodilator response and airway cytology as parameters for asthma control: A randomized clinical trial Protocol ID: APITA, NCT00597064, on August 1st, 2008
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Challenges in IPF trials: the point on endpoints
Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions
Year: 2010

Tiotropium in severe asthma: an open label review of clinical efficacy
Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma
Year: 2007


Precision medicine in airway diseases: moving to clinical practice
Source: Eur Respir J, 50 (4) 1701655; 10.1183/13993003.01655-2017
Year: 2017



Clinical efficacy of new non-freon aerosol troventol in asthma patients
Source: Annual Congress 2006 - Recent advances in asthma treatment
Year: 2006

Safety of formoterol in children and adolescents: experience from asthma clinical trials
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Genetic studies in asthma and COPD: what have we learned?
Source: Annual Congress 2011 - PG5 Asthma versus COPD: similarities and differences
Year: 2011



Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy?
Source: Eur Respir J 2006; 28: Suppl. 50, 319s
Year: 2006

Late-breaking abstract: Nasal symptoms are common in subjects with COPD and concomitant heart disease
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011

Clinical trials are important for CAP and other LRTI syndromes: but how to understand and interpret?
Source: Annual Congress 2010 - PG17 GRACE Postgraduate Course: Antimicrobial treatment of LRTI: important new aspects for clinical practice
Year: 2010